Ranibizumab
91689
Phase 3 small_molecule completed
Quick answer
Ranibizumab for Macular Degeneration is a Phase 3 program (small_molecule) at Regeneron UK Limited with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Regeneron UK Limited
- Indication
- Macular Degeneration
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed